Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Vertex: In Pursuit of Cures

September 4, 2019 0

Vertex Pharmaceuticals Is Acquiring Semma Therapeutics Vertex Pharmaceutical (VRTX) entered into a definitive agreement to buy a …

Outperforming Biotechs In a Bad Market Day

September 3, 2019 0

Outperforming Biotechs On August 27, 2019 we posted “The Medicines Company Has Agreeable News” under Today’s …

Gene Therapy and Other Treatments That Work at the Genetic Level

August 30, 2019 0

Gene Therapy Stocks Experiencing Selloffs Every investor in the biotech sector must have experienced selloffs of …

The Medicines Company Has Agreeable News

August 27, 2019 0

The Medicines Company The Medicines Company (MDCO) focuses on cardiovascular diseases. Major goals are halting the …

Amgen to Acquire Celgene’s Product Otezla at $13.4 Billion

August 26, 2019 0

Amgen Agreement with Celgene for Otezla® In the News Amgen (AMGN) entered into an agreement with …

AstraZeneca and Vertex Both Have Good News

August 21, 2019 0

AstraZeneca: Farxiga for Heart Failure with Reduced Ejection Fraction AstraZeneca (AZN) has good news. Many of them …

Moderna’s Investigational Zika Vaccine Is Granted FDA Fast Track Designation

August 20, 2019 0

From Moderna From the press release we learned that the U.S. Food and Drug Administration (FDA) …

The Bizarre Market

August 20, 2019 0

The Week in Review #41 We Are Still Witnessing … The bizarre market performance that started …

Why Akari Therapeutics Stock Price Rallied Today

August 14, 2019 0

Akari Therapeutics Stock Rallied Autoimmune and inflammatory disease treatments are works in progress with some approved …

Regeneron: Successful Cure for Ebola-Infected People. Read Also: The Midday Outperforming Biotech Stocks

August 13, 2019 0

Regeneron Product REGN-EB3 Saving Lives Regeneron (REGN) announced that an independent monitoring board ended its investigational product …

A Press Release About Regeneron Product REGN-EB3 Showing Superiority in Preventing Ebola Deaths

August 13, 2019 0

Palm Ebola Clinical Trial Stopped Early as Regeneron Product REGN-EB3 Therapy Shows Superiority to ZMapp in …

The Value of the Biotech Companies

August 12, 2019 0

Prohost Letter #434 Special Issue The Value of the Biotech Companies With a strong economy and …

Why Amgen’s Stock Is Up Over $11 Today

August 9, 2019 0

Amgen’s Stock Is Up Amgen (AMGN) is speeding towards reaching its true, fair value. In the Q2 …

Court Upholds Validity of Amgen’s Claims Regarding Enbrel

August 9, 2019 0

Press Release Amgen Wins Patent Case On Enbrel® (etanercept) Court Upholds Validity of Patent Claims Directed …

Nektar’s Story Has Nothing to Do with the Efficacy Or the Value of NKTR-214

August 9, 2019 2

Nektar Therapeutics Story Everything was going well with Nektar Therapeutics (NKTR) stock during the Conference call …

Nektar Therapeutics Q2 Results for 2019 Press Release

August 9, 2019 0

Nektar Press Release Nektar Therapeutics Results for Q2 of 2019 Nektar Therapeutics (Nasdaq: NKTR) reported its financial …

Unveiled Good News About Prohost Picked Biotech Stocks

August 8, 2019 0

The News Prohost Was Waiting for to Post Its Special Letter Prohost has one eye on …

Rhythm Pharmaceuticals Has Good News. See Also: The Novartis News Story

August 7, 2019 0

Rhythm Pharmaceuticals From Rhythm Pharmaceuticals (RYTM) we learned that positive, top-line results from two pivotal Phase 3 …

What We Learned from Yesterday’s and Today’s Stocks’ Moves

August 6, 2019 0

What Have We Learned from the Market's Recent Stock Moves? Well. Did we learn anything from …

Impacting News

August 6, 2019 0

In This Column Every day thousands of press releases are issued about biotechnology and pharmaceutical firms. …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Vertex: In Pursuit of Cures

Outperforming Biotechs In a Bad Market Day

Gene Therapy and Other Treatments That Work at the Genetic Level

The Medicines Company Has Agreeable News

Amgen to Acquire Celgene’s Product Otezla at $13.4 Billion

AstraZeneca and Vertex Both Have Good News

Moderna’s Investigational Zika Vaccine Is Granted FDA Fast Track Designation

The Bizarre Market

Why Akari Therapeutics Stock Price Rallied Today

Regeneron: Successful Cure for Ebola-Infected People. Read Also: The Midday Outperforming Biotech Stocks

A Press Release About Regeneron Product REGN-EB3 Showing Superiority in Preventing Ebola Deaths

The Value of the Biotech Companies

Why Amgen’s Stock Is Up Over $11 Today

Court Upholds Validity of Amgen’s Claims Regarding Enbrel

Nektar’s Story Has Nothing to Do with the Efficacy Or the Value of NKTR-214

Nektar Therapeutics Q2 Results for 2019 Press Release

Unveiled Good News About Prohost Picked Biotech Stocks

Rhythm Pharmaceuticals Has Good News. See Also: The Novartis News Story

What We Learned from Yesterday’s and Today’s Stocks’ Moves

Impacting News